PetrJarolimMD

Blood Banking & Transfusion Medicine, Chemical Pathology, Clinical Pathology

Professor of Pathology, Harvard Medical School

Dr. Jarolim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
75 Francis St
# Brigham
Boston, MA 02115
Phone+1 617-732-4725

Fax+1 917-731-4872

Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Blood Banking/Transfusion Medicine, 1996 - 1997
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1994 - 1997

PubMed

Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.
Usman A Tahir, Paul Kolm, Raymond Y Kwong, Milind Y Desai, Sarahfaye F Dolman
Circulation. Heart Failure. 2024-11-05
1 citations
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.
Paul M Haller, Petr Jarolim, Michael G Palazzolo, Andrea Bellavia, Elliott M Antman
Journal of the American College of Cardiology. 2024-10-15
Convergence of SARS-CoV-2 spike antibody levels to a population immune setpoint.
Eric J Nilles, Kathryn Roberts, Michael de St Aubin, Helen Mayfield, Angela Cadavid Restrepo
Ebiomedicine. 2024-10-01

Journal Articles

Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines
Nicholas A Marston, Marc P Bonaca, Petr Jarolim, Deepak L Bhatt, Stephen D Wiviott, Eugene Braunwald, Marc S Sabatine, JAMA Cardiology
Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients
Petr Jarolim, Basma Merhi, Andrew Bostom, Nora Franceschini, American Journal of Nephrology
Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus in the EXAMINE Trial
William B White, Petr Jarolim, Diabetes Care

Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesAugust 2020

Community-Based Rapid NGS Offers Considerable Advantages in Clinical Cancer CareAugust 3rd, 2022
Serial NT-proBNP Found to Identify Risk for Adverse CV OutcomesAugust 17th, 2018
Elevated NT-proBNP Found to up Cardiovascular Risk in T2DMJune 15th, 2018
Join now to see all